SCR-LIP-000470 · Claim · machine-readable JSON →
In lipedema patients, platelet count, CRP, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) were significantly higher than in controls (p<0.05), while MPV and PDW did not differ, and the inflammatory findings were not explained by BMI differences, supporting a low-grade systemic inflammatory component in lipedema.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Inflammatory Markers in Lipedema: A Comparative Analysis of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume (2026) ✓ verified — consistent · cross sectional · 2026 · reading confidence: high
“Marcadores hematológicos de inflamação sistêmica de baixo grau — NLR, PLR e PCR — estão elevados no lipedema em comparação com controles, apoiando um componente inflamatório na doença.”
The study reports elevated systemic low-grade inflammation markers in lipedema vs controls, not explained by BMI, directly supporting an inflammatory component in the disease.
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000011
- 2026-11-20 — consolidated · SQ-LIP-000011: evidence moved to SCR-LIP-000636